Hovione and IDC Intranasal Drug Delivery Platform Available for Commercial Partnerships
Its lead single-use nasal dry powder device now available for commercial partnerships
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Its lead single-use nasal dry powder device now available for commercial partnerships
Hovione today announced the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022
The agreement furthers Hovione´s ability to bring the benefits of continuous tableting, including reduced time to market and increased supply chain flexibility, to pharmaceutical customers globally
Presented by the Hénokiens Association and the Château du Clos Lucé
EY Entrepreneur Of The Year is the world's most prestigious business award for entrepreneurs
C&EN, 26 September 2021
Investment in Hovione Tejo will expand industrial capacity and strengthen the company’s global leadership in spray drying and other advanced pharmaceutical manufacturing technologies.